Javid Fazili to Liver Cirrhosis
This is a "connection" page, showing publications Javid Fazili has written about Liver Cirrhosis.
Connection Strength
0.597
-
From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. Int J Mol Sci. 2024 Jun 12; 25(12).
Score: 0.222
-
Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosis. Eur J Gastroenterol Hepatol. 2018 Mar; 30(3):296-301.
Score: 0.143
-
Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014 May 14; 20(18):5442-60.
Score: 0.110
-
Development and validation of a model to diagnose cirrhosis in patients with hepatitis C. Am J Gastroenterol. 2002 Oct; 97(10):2623-8.
Score: 0.049
-
Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical ß-catenin-dependent mechanism. Sci Rep. 2020 06 29; 10(1):10578.
Score: 0.042
-
Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism. Oncotarget. 2015 Nov 10; 6(35):37200-15.
Score: 0.031